SYRA HEALTH CORP.: 10-Q filed 2023-11-14

Name: SYRA HEALTH CORP.: 10-Q filed 2023-11-14
Creator: SYRA HEALTH CORP.

What SYRA HEALTH CORP. reported in its quarterly report filed 2023-11-14 (fiscal Q3 2023): 38 published measures, 106 facts as tagged in accession 0001493152-23-040869.

This filing

Form: 10-Q (quarterly report)
Filed: 2023-11-14
Fiscal period: fiscal Q3 2023
Accession: 0001493152-23-040869 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SYRA HEALTH CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2023-09-30	2,606,818	USD
At 2022-12-31	2,319,642	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2023-09-30	3,836,119	USD
At 2022-12-31	1,609,544	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2023-09-30	-1,229,301	USD
At 2023-06-30	-876,004	USD
At 2022-12-31	710,098	USD
At 2022-09-30	1,320,971	USD
At 2022-06-30	1,159,435	USD
At 2021-12-31	-7,147	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2023-09-30	18,010	USD
At 2022-12-31	3,344	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-354,376	USD	92
2023-01-01 to 2023-09-30	-1,943,068	USD	273
2022-07-01 to 2022-09-30	-354,535	USD	92
2022-01-01 to 2022-09-30	-1,505,533	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	-1,002,026	USD	273
2022-01-01 to 2022-09-30	-1,022,661	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	15,251	USD	273
2022-01-01 to 2022-09-30	76,358	USD	273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	1,581,344	USD	92
2023-01-01 to 2023-09-30	3,748,943	USD	273
2022-07-01 to 2022-09-30	1,513,979	USD	92
2022-01-01 to 2022-09-30	3,651,978	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	1,031,943	USD	273
2022-01-01 to 2022-09-30	1,667,536	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	-15,251	USD	273
2022-01-01 to 2022-09-30	-76,358	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2023-09-30	-4,069,680	USD
At 2022-12-31	-2,126,612	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	4,360,426	shares	92
2023-01-01 to 2023-09-30	4,380,267	shares	273
2022-07-01 to 2022-09-30	4,107,164	shares	92
2022-01-01 to 2022-09-30	2,337,915	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	4,360,426	shares	92
2023-01-01 to 2023-09-30	4,380,267	shares	273
2022-07-01 to 2022-09-30	4,107,164	shares	92
2022-01-01 to 2022-09-30	2,337,915	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-0.08	USD/shares	92
2023-01-01 to 2023-09-30	-0.44	USD/shares	273
2022-07-01 to 2022-09-30	-0.09	USD/shares	92
2022-01-01 to 2022-09-30	-0.64	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-0.08	USD/shares	92
2023-01-01 to 2023-09-30	-0.44	USD/shares	273
2022-07-01 to 2022-09-30	-0.09	USD/shares	92
2022-01-01 to 2022-09-30	-0.64	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	0	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2023-09-30	91,331	USD
At 2022-12-31	112,493	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	3,669	USD	273
2022-01-01 to 2022-09-30	1,151	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-343,016	USD	92
2023-01-01 to 2023-09-30	-1,901,445	USD	273
2022-07-01 to 2022-09-30	-346,791	USD	92
2022-01-01 to 2022-09-30	-1,488,946	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2023-09-30	1,236,184	USD
At 2022-12-31	1,426,743	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	14,180	USD	92
2023-01-01 to 2023-09-30	44,449	USD	273
2022-07-01 to 2022-09-30	7,779	USD	92
2022-01-01 to 2022-09-30	16,641	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2023-09-30	2,381,119	USD
At 2022-12-31	1,546,345	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2023-09-30	1,054,851	USD
At 2022-12-31	1,201,097	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	897,557	USD	92
2023-01-01 to 2023-09-30	2,731,301	USD	273
2022-07-01 to 2022-09-30	760,600	USD	92
2022-01-01 to 2022-09-30	2,259,782	USD	273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	554,541	USD	92
2023-01-01 to 2023-09-30	829,856	USD	273
2022-07-01 to 2022-09-30	413,809	USD	92
2022-01-01 to 2022-09-30	770,836	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	234,084	USD	92
2023-01-01 to 2023-09-30	657,904	USD	273
2022-07-01 to 2022-09-30	150,492	USD	92
2022-01-01 to 2022-09-30	370,067	USD	273

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2023-09-30	18,010,000	USD
At 2022-12-31	3,344,000	USD
At 2022-09-30	668,529,000	USD
At 2021-12-31	100,012,000	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2023-09-30	2,836,019	USD
At 2022-12-31	2,832,308	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2023-09-30	94,126	USD
At 2022-12-31	184,288	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2023-09-30	94,126	USD
At 2022-12-31	184,288	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2023-09-30	51,469	USD
At 2022-12-31	15,056	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2023-09-30	274,596	USD
At 2022-12-31	239,117	USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	12,357	USD	92
2023-01-01 to 2023-09-30	36,413	USD	273
2022-07-01 to 2022-09-30	3,880	USD	92
2022-01-01 to 2022-09-30	4,791	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-11,360	USD	92
2023-01-01 to 2023-09-30	-41,623	USD	273
2022-07-01 to 2022-09-30	-7,744	USD	92
2022-01-01 to 2022-09-30	-16,587	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	28,533,000	USD	273
2022-01-01 to 2022-09-30	6,526,000	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	2,322,500	USD	273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	90,162	USD	273
2022-01-01 to 2022-09-30	66,361	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	-136,324	USD	273
2022-01-01 to 2022-09-30	355,483	USD	273

Inspect the source

Entity: SYRA HEALTH CORP. / CIK 0001922335
Captured: 2026-09-21T17:41:11.939Z
SEC response SHA-256: b7deb50e336dc97b3dc95be11b8ad17619851faa670b1bd5b706682829760083

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001922335.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))